Published in Neuropathology on October 15, 2012
Brain arterial remodeling contribution to nonembolic brain infarcts in patients with HIV. Neurology (2015) 1.45
Determinants of cerebrovascular remodeling: do large brain arteries accommodate stenosis? Atherosclerosis (2014) 0.97
A pathological perspective on the natural history of cerebral atherosclerosis. Int J Stroke (2015) 0.91
Brain large artery inflammation associated with HIV and large artery remodeling. AIDS (2016) 0.80
Value of perfusion-weighted MR imaging in the assessment of early cerebral alterations in neurologically asymptomatic HIV-1-positive and HCV-positive patients. PLoS One (2014) 0.79
MR Imaging Measures of Intracranial Atherosclerosis in a Population-based Study. Radiology (2016) 0.77
Histopathological Differences Between the Anterior and Posterior Brain Arteries as a Function of Aging. Stroke (2017) 0.75
Metalloproteinases and Brain Arterial Remodeling Among Individuals With and Those Without HIV Infection. J Infect Dis (2016) 0.75
Class of antiretroviral drugs and the risk of myocardial infarction. N Engl J Med (2007) 12.93
Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr (2006) 12.07
Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med (1987) 9.79
Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection. Circulation (2004) 4.87
Hyperelastic modelling of arterial layers with distributed collagen fibre orientations. J R Soc Interface (2006) 4.35
The emerging concept of vascular remodeling. N Engl J Med (1994) 4.27
Modelling covariance structure in the analysis of repeated measures data. Stat Med (2000) 4.03
Epidemiological evidence for cardiovascular disease in HIV-infected patients and relationship to highly active antiretroviral therapy. Circulation (2008) 2.64
Antiretroviral therapy reduces markers of endothelial and coagulation activation in patients infected with human immunodeficiency virus type 1. J Infect Dis (2002) 2.46
Natural history of vertebrobasilar dolichoectasia. Neurology (2008) 2.14
Influence of mechanical, cellular, and molecular factors on collateral artery growth (arteriogenesis). Circ Res (2004) 2.08
Human immunodeficiency virus (HIV) infects human arterial smooth muscle cells in vivo and in vitro: implications for the pathogenesis of HIV-mediated vascular disease. Am J Pathol (2008) 1.60
Stroke in patients with human immunodeficiency virus infection. J Neurol Neurosurg Psychiatry (2007) 1.55
The impact of atherosclerotic arterial remodeling on percentage of luminal stenosis varies widely within the arterial system. A postmortem study. Arterioscler Thromb Vasc Biol (1997) 1.48
Clinicopathological study of intracranial fusiform and dolichoectatic aneurysms : insight on the mechanism of growth. Stroke (2000) 1.48
Cerebral infarction in adult AIDS patients: observations from the Edinburgh HIV Autopsy Cohort. Stroke (2000) 1.44
Acquired immunodeficiency syndrome and the risk of stroke. Stroke (2003) 1.42
Cerebral aneurysmal arteriopathy in childhood AIDS. Neurology (1998) 1.39
Large artery vasculopathy in HIV-positive patients: another vasculitic enigma. Hum Pathol (2000) 1.33
Mechanisms of ischemic stroke in HIV-infected patients. Neurology (2007) 1.29
Arterial enlargement, tortuosity, and intimal thickening in response to sequential exposure to high and low wall shear stress. J Vasc Surg (2004) 1.27
Adaptive remodeling of internal elastic lamina and endothelial lining during flow-induced arterial enlargement. Arterioscler Thromb Vasc Biol (1999) 1.26
Effects of HIV infection and antiretroviral therapy on the heart and vasculature. Circulation (2008) 1.25
Dolichoectasia-an evolving arterial disease. Nat Rev Neurol (2011) 1.25
Aortic endothelium in HIV-1 infection: chronic injury, activation, and increased leukocyte adherence. Am J Pathol (1996) 1.25
In vivo assessment of rapid cerebrovascular morphological adaptation following acute blood flow increase. J Neurosurg (2008) 1.19
[Vertebrobasilar arterial dolichoectasia. Complications and prognosis]. Rev Neurol (Paris) (1991) 1.07
HIV-1 envelope glycoprotein 120 increases intercellular adhesion molecule-1 expression by human endothelial cells. Lab Invest (2002) 1.01
Basilar artery diameter and 5-year mortality in patients with stroke. Stroke (2006) 1.00
Thinning of the arterial media layer as a possible preclinical stage in HIV vasculopathy: a pilot study. Stroke (2011) 0.99
Productive HIV-1 infection of human vascular endothelial cells requires cell proliferation and is stimulated by combined treatment with interleukin-1 beta plus tumor necrosis factor-alpha. J Med Virol (1995) 0.96
HIV/AIDS patients with HIV vasculopathy and VZV vasculitis: a case series. Clin Neuroradiol (2011) 0.90
Basilar artery dolichoectasia is associated with paramedian pontine infarction. Cerebrovasc Dis (2008) 0.89
Age-related changes in reticulin fibers and other connective tissue elements in the intima of the major intracranial arteries. Clin Neuropathol (1989) 0.80
A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med (2013) 9.97
Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation (2009) 8.11
Ischemic stroke subtype incidence among whites, blacks, and Hispanics: the Northern Manhattan Study. Circulation (2005) 4.08
An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2013) 3.60
Symptomatic intracerebral hemorrhage among eligible warfarin-treated patients receiving intravenous tissue plasminogen activator for acute ischemic stroke. Arch Neurol (2010) 3.49
Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2014) 3.48
Altered editing of serotonin 2C receptor pre-mRNA in the prefrontal cortex of depressed suicide victims. Neuron (2002) 3.06
Antidepressants increase neural progenitor cells in the human hippocampus. Neuropsychopharmacology (2009) 2.63
Transesophageal echocardiography in cryptogenic stroke and patent foramen ovale: analysis of putative high-risk features from the risk of paradoxical embolism database. Circ Cardiovasc Imaging (2013) 2.56
Ideal cardiovascular health predicts lower risks of myocardial infarction, stroke, and vascular death across whites, blacks, and hispanics: the northern Manhattan study. Circulation (2012) 2.48
Traditional risk factors are not major contributors to the variance in carotid intima-media thickness. Stroke (2013) 2.34
Long-term functional recovery after first ischemic stroke: the Northern Manhattan Study. Stroke (2009) 2.33
Risk of myocardial infarction or vascular death after first ischemic stroke: the Northern Manhattan Study. Stroke (2007) 2.30
An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke. Neurology (2013) 2.26
Advancing the study of stroke in women: summary and recommendations for future research from an NINDS-Sponsored Multidisciplinary Working Group. Stroke (2006) 2.17
Association between incident cancer and subsequent stroke. Ann Neurol (2015) 2.13
Antidepressant-induced neurogenesis in the hippocampus of adult nonhuman primates. J Neurosci (2007) 2.12
Insulin resistance and risk of ischemic stroke among nondiabetic individuals from the northern Manhattan study. Arch Neurol (2010) 2.00
Experimental treatments for acute ischaemic stroke. Lancet (2007) 1.97
Prevalence and prognostic value of subclinical left ventricular systolic dysfunction by global longitudinal strain in a community-based cohort. Eur J Heart Fail (2014) 1.96
Stroke location and association with fatal cardiac outcomes: Northern Manhattan Study (NOMAS). Stroke (2008) 1.91
Mediterranean-style diet and risk of ischemic stroke, myocardial infarction, and vascular death: the Northern Manhattan Study. Am J Clin Nutr (2011) 1.91
Inter-individual variability in the capacity for motor recovery after ischemic stroke. Neurorehabil Neural Repair (2007) 1.86
Type III neuregulin-1 is required for normal sensorimotor gating, memory-related behaviors, and corticostriatal circuit components. J Neurosci (2008) 1.80
Patent foramen ovale and migraine: a cross-sectional study from the Northern Manhattan Study (NOMAS). Circulation (2008) 1.77
Infectious burden and cognitive function: the Northern Manhattan Study. Neurology (2013) 1.77
Lipid profile components and risk of ischemic stroke: the Northern Manhattan Study (NOMAS). Arch Neurol (2009) 1.74
Reemergence of stroke deficits with midazolam challenge. Stroke (2002) 1.73
Improvement in aphasia scores after stroke is well predicted by initial severity. Stroke (2010) 1.72
Diabetes, fasting glucose levels, and risk of ischemic stroke and vascular events: findings from the Northern Manhattan Study (NOMAS). Diabetes Care (2008) 1.69
Dietary sodium and risk of stroke in the Northern Manhattan study. Stroke (2012) 1.65
Subclinical left ventricular dysfunction and silent cerebrovascular disease: the Cardiovascular Abnormalities and Brain Lesions (CABL) study. Circulation (2013) 1.61
Effect of obesity and overweight on left ventricular diastolic function: a community-based study in an elderly cohort. J Am Coll Cardiol (2011) 1.61
CKD associates with cognitive decline. J Am Soc Nephrol (2009) 1.55
Improving global vascular risk prediction with behavioral and anthropometric factors. The multiethnic NOMAS (Northern Manhattan Cohort Study). J Am Coll Cardiol (2009) 1.52
Patent foramen ovale, subclinical cerebrovascular disease, and ischemic stroke in a population-based cohort. J Am Coll Cardiol (2013) 1.52
Pulsatile and steady components of blood pressure and subclinical cerebrovascular disease: the Northern Manhattan Study. J Hypertens (2015) 1.48
Necessity of hippocampal neurogenesis for the therapeutic action of antidepressants in adult nonhuman primates. PLoS One (2011) 1.45
Prevalence and quality of endodontic treatment in the Northern Manhattan elderly. J Endod (2007) 1.45
Arterial stiffness and wave reflection: sex differences and relationship with left ventricular diastolic function. Hypertension (2012) 1.41
Diet soft drink consumption is associated with an increased risk of vascular events in the Northern Manhattan Study. J Gen Intern Med (2012) 1.37
Nontechnical skills in anesthesia crisis management with repeated exposure to simulation-based education. Anesthesiology (2005) 1.36
Risk of a thrombotic event after the 6-week postpartum period. N Engl J Med (2014) 1.34
Improvement after constraint-induced movement therapy: recovery of normal motor control or task-specific compensation? Neurorehabil Neural Repair (2012) 1.33
The risk of paradoxical embolism (RoPE) study: initial description of the completed database. Int J Stroke (2012) 1.32
Duration of diabetes and risk of ischemic stroke: the Northern Manhattan Study. Stroke (2012) 1.32
Hemicraniectomy for massive middle cerebral artery territory infarction: a systematic review. Stroke (2004) 1.32
Inflammatory biomarkers of vascular risk as correlates of leukoariosis. Stroke (2009) 1.32
Construct validity of cognitive reserve in a multiethnic cohort: The Northern Manhattan Study. J Int Neuropsychol Soc (2009) 1.30
Measures of adiposity and future risk of ischemic stroke and coronary heart disease in older men and women. Am J Epidemiol (2010) 1.26
Hippocampal angiogenesis and progenitor cell proliferation are increased with antidepressant use in major depression. Biol Psychiatry (2012) 1.25
Carotid plaque surface irregularity predicts ischemic stroke: the northern Manhattan study. Stroke (2006) 1.25
The vascular effects of infection in Pediatric Stroke (VIPS) Study. J Child Neurol (2011) 1.23
Left atrial minimum volume and reservoir function as correlates of left ventricular diastolic function: impact of left ventricular systolic function. Heart (2012) 1.23
Metabolic syndrome, endothelial dysfunction, and risk of cardiovascular events: the Northern Manhattan Study (NOMAS). Am Heart J (2008) 1.22
Stochastic approximation with virtual observations for dose-finding on discrete levels. Biometrika (2009) 1.21
Neocortical and hippocampal neuron and glial cell numbers in the rhesus monkey. Anat Rec (Hoboken) (2007) 1.21
Septal pouch in the left atrium and risk of ischemic stroke. JACC Cardiovasc Imaging (2010) 1.20
Abnormalities of SNARE mechanism proteins in anterior frontal cortex in severe mental illness. Cereb Cortex (2002) 1.18
Association of serum soluble receptor for advanced glycation end-products with subclinical cerebrovascular disease: the Northern Manhattan Study (NOMAS). Atherosclerosis (2011) 1.17
Hippocampal granule neuron number and dentate gyrus volume in antidepressant-treated and untreated major depression. Neuropsychopharmacology (2013) 1.16
Social determinants of physical inactivity in the Northern Manhattan Study (NOMAS). J Community Health (2010) 1.14
The Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH) study protocol. Stroke (2013) 1.14
Paroxysmal supraventricular tachycardia and the risk of ischemic stroke. Stroke (2013) 1.14
Intravenous thrombolytic treatment of acute ischemic stroke associated with left atrial myxoma: a case report. J Stroke Cerebrovasc Dis (2007) 1.13
Incidence and risk factors of intracranial atherosclerotic stroke: the Northern Manhattan Stroke Study. Cerebrovasc Dis (2009) 1.13
Interleukin-6 is associated with cognitive function: the Northern Manhattan Study. J Stroke Cerebrovasc Dis (2007) 1.13
Traditional cardiovascular risk factors explain the minority of the variability in carotid plaque. Stroke (2012) 1.13
Effect of diabetes and hypertension on left ventricular diastolic function in a high-risk population without evidence of heart disease. Eur J Heart Fail (2010) 1.12
Stroke, cognitive deficits, and rehabilitation: still an incomplete picture. Int J Stroke (2013) 1.12
Hippocampal complexin proteins and cognitive dysfunction in schizophrenia. Arch Gen Psychiatry (2005) 1.11
Amino terminal pro-B-type natriuretic peptide, secondary stroke prevention, and choice of antithrombotic therapy. Stroke (2013) 1.11
Outpatient training in neurology: history and future challenges. Neurology (2006) 1.10
Vertebrobasilar Flow Evaluation and Risk of Transient Ischaemic Attack and Stroke study (VERiTAS): rationale and design. Int J Stroke (2010) 1.09
Early-life stress, corpus callosum development, hippocampal volumetrics, and anxious behavior in male nonhuman primates. Psychiatry Res (2011) 1.09
Early depressed mood after stroke predicts long-term disability: the Northern Manhattan Stroke Study (NOMASS). Stroke (2010) 1.09
The growing problem of stroke among young adults. Curr Cardiol Rep (2013) 1.09
Daytime sleepiness and risk of stroke and vascular disease: findings from the Northern Manhattan Study (NOMAS). Circ Cardiovasc Qual Outcomes (2012) 1.08
3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors in the treatment of central nervous system diseases. Arch Neurol (2010) 1.08
LA volumes and reservoir function are associated with subclinical cerebrovascular disease: the CABL (Cardiovascular Abnormalities and Brain Lesions) study. JACC Cardiovasc Imaging (2013) 1.08
Neuroimaging in stroke recovery: a position paper from the First International Workshop on Neuroimaging and Stroke Recovery. Cerebrovasc Dis (2004) 1.07
Recent developments regarding human immunodeficiency virus infection and stroke. Cerebrovasc Dis (2012) 1.07
Nonconvulsive seizures in subarachnoid hemorrhage link inflammation and outcome. Ann Neurol (2014) 1.06
Endothelial dysfunction is associated with carotid plaque: a cross-sectional study from the population based Northern Manhattan Study. BMC Cardiovasc Disord (2006) 1.05
Lipids and carotid plaque in the Northern Manhattan Study (NOMAS). BMC Cardiovasc Disord (2009) 1.04
The role of indirect extracranial-intracranial bypass in the treatment of symptomatic intracranial atheroocclusive disease. J Neurosurg (2009) 1.04
Prediction of motor recovery using initial impairment and fMRI 48 h poststroke. Cereb Cortex (2011) 1.04
Multiethnic genome-wide association study of cerebral white matter hyperintensities on MRI. Circ Cardiovasc Genet (2015) 1.03
Genome-wide divergence of DNA methylation marks in cerebral and cerebellar cortices. PLoS One (2010) 1.03
Relationship between C-reactive protein, systemic oxygen consumption, and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. Stroke (2011) 1.03
Adiponectin and carotid intima-media thickness in the northern Manhattan study. Stroke (2011) 1.02
Inclusion of stroke as an outcome and risk equivalent in risk scores for primary and secondary prevention of vascular disease. Circulation (2010) 1.01
Alterations in plasma complement levels after human ischemic stroke. Neurosurgery (2006) 1.00
Baseline and longitudinal increases in diastolic blood pressure are associated with greater white matter hyperintensity volume: the northern Manhattan study. Stroke (2011) 1.00
Clinical features, surgical treatment, and long-term outcome in adult patients with moyamoya disease. Clinical article. J Neurosurg (2009) 1.00